Company intelligence / Profile preview

Integrated Laboratory Systems

Morrisville, North Carolina, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Integrated Laboratory Systems (ILS) is a contract research organization (CRO) now operating as a wholly owned subsidiary of Inotiv. It offers a comprehensive suite of toxicology, pathology, molecular biology, and computational toxicology services. These services are provided to pharmaceutical, chemical, agrochemical, food additive, and consumer product industries, as well as federal agencies. ILS specializes in genetic and investigative toxicology services, ensuring compliance with GLP and international regulatory requirements. As a service provider, ILS does not develop its own therapeutic pipeline or drugs.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Integrated Laboratory Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrated Laboratory Systems.

Explore the full profile